Karl-Erik Andersson
131 – 140 of 171
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2002
-
Mark
Actions of the new antimuscarinic compound Lu 25-109 on isolated human and pig detrusor.
(
- Contribution to journal › Article
-
Mark
Effects of NAD-299, a new, highly selective 5-HT(1A) receptor antagonist, on bladder function in rats.
(
- Contribution to journal › Article
-
Mark
Bladder activation: afferent mechanisms.
(
- Contribution to journal › Article
-
Mark
Treatment of the overactive bladder: possible central nervous system drug targets.
(
- Contribution to journal › Article
-
Mark
Overview consensus statement
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Tamsulosin: an overview
(
- Contribution to journal › Article
-
Mark
Potential benefits of muscarinic M-3 receptor selectivity
(
- Contribution to journal › Article
-
Mark
What is nocturnal polyuria?
(
- Contribution to journal › Article
-
Mark
The pharmacological treatment of nocturia
(
- Contribution to journal › Article
-
Mark
Pharmacologic perspective on the physiology of the lower urinary tract.
(
- Contribution to journal › Article